0002112446 2026-04-02 2026-04-02 0002112446 jatt:ExecutiveOfficersAndDirectorsMember 2026-04-02 2026-04-02 0002112446 jatt:InitialShareholdersMember 2026-04-02 2026-04-02 0002112446 jatt:OfficersDirectorsAndAdvisorsMember 2026-04-02 2026-04-02 0002112446 spac:SpacSponsorCompensationMember 2026-04-02 2026-04-02 0002112446 jatt:UnderwritersOverAllotmentOptionMember spac:SpacSponsorCompensationMember 2026-04-02 2026-04-02 0002112446 spac:CommonSharesMember 2026-04-02 2026-04-02 0002112446 jatt:JATTIIAcquisitionSponsorMember 2026-04-02 2026-04-02 0002112446 jatt:DrSomeitSidhuMember 2026-04-02 2026-04-02 0002112446 jatt:MrNicholasFernandezMember 2026-04-02 2026-04-02 0002112446 jatt:IndependentDirectorsMember 2026-04-02 2026-04-02 0002112446 jatt:IndependentConsultantMember 2026-04-02 2026-04-02 0002112446 spac:CommonSharesMember jatt:JATTIIAcquisitionSponsorMember 2026-04-02 2026-04-02 0002112446 jatt:PrivatePlacementSharesMember 2026-04-02 2026-04-02 0002112446 jatt:JATTIIAcquisitionSponsorAndAffliatesMember 2026-04-02 2026-04-02 0002112446 spac:FounderSharesMember 2026-04-02 2026-04-02 0002112446 jatt:PrivatePlacementWarrantsMember 2026-04-02 2026-04-02 0002112446 jatt:NoOverAllotmentMember spac:NoRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:NoRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:NoRedemptionMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:NoRedemptionMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:OfferingCostPaidInAdvanceExcludedFromTangibleBookValueMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:NoRedemptionMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:NoRedemptionMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember spac:DeferredUnderwritingCommissionsMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:NoRedemptionMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:NoRedemptionMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember spac:OverallotmentLiabilityMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:NoRedemptionMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:NoRedemptionMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:AmountPaidForRedemptionMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:NoRedemptionMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:NoRedemptionMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:NoRedemptionMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:NoRedemptionMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:OrdinarySharesOfferedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:NoRedemptionMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:NoRedemptionMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:PrivatePlacementSharesMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:NoRedemptionMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:NoRedemptionMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt25PercentOfMaximumMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt50PercentOfMaximumMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt75PercentOfMaximumMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 0002112446 jatt:NoOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 0002112446 jatt:FullOverAllotmentMember spac:RedemptionAt100PercentOfMaximumMember jatt:OrdinarySharesRedeemedMember 2026-02-13 2026-02-13 pure shares iso4217:USD shares iso4217:USD AMENDMENT NO. 1 JATT II ACQUISITION CORP E9 Non-accelerated Filer true true false true true As further described in this prospectus, our articles provide that a public shareholder, together with any affiliate or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended, the “Exchange Act”), will be restricted from redeeming its public shares with respect to more than an aggregate of 20% of the public shares sold in this offering, without our prior consent. Each public shareholder may elect to redeem their public shares irrespective of whether they vote for or against an initial business combination, or whether they do not vote or abstain from voting on the initial business combination, and regardless of whether they hold public shares on the record date established in connection with our initial business combination.If we are unable to complete our initial business combination within the completion window, we will redeem 100% of the public shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (less taxes paid or payable (other than excise or similar taxes) and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, subject to applicable law and certain limitations and on the conditions as further described herein. We may seek shareholder approval to amend our articles to extend the date by which we must consummate our initial business combination. If we seek shareholder approval for an extension, holders of our public shares will be offered an opportunity to redeem their shares upon approval of such extension, regardless of whether they abstain, vote in favor of or vote against such extension. 300000 309000 10 3000000 3090000 The following table illustrates the difference between the public offering price and our net tangible book value per share, as adjusted to reflect various potential redemption levels that may occur in connection with the closing of our initial business combination, which we refer to as Adjusted NTBVPS, on a pro forma basis to give effect to this offering and the issuance of the private placement shares, assuming no exercise of the over-allotment option and exercise of the over-allotment option in full. Adjusted NTBVPS excludes the effect of the consummation of our initial business combination or any related transactions or expenses. See the section titled “Dilution” for more information.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td colspan="34" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">As of February 13, 2026</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Offering Price of $10.00, No Redemptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">25% of Maximum Redemptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">50% of Maximum Redemptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">75% of Maximum Redemptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Maximum Redemptions</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Adjusted NTBVPS</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Adjusted NTBVPS</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Difference between adjusted NTBVPS and Offering Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Adjusted NTBVPS</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Difference between adjusted NTBVPS and Offering Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Adjusted NTBVPS</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Difference between adjusted NTBVPS and Offering Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Adjusted NTBVPS</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid">Difference between adjusted NTBVPS and Offering Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="34" style="font: italic 10pt Times New Roman, Times, Serif; text-align: center">Assuming Full Exercise of Over-Allotment Option</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.66</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.90</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6.19</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.81</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4.44</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.56</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.28</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10.28</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td colspan="34" style="font: italic 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -10pt; padding-left: 10pt">Assuming No Exercise of Over-Allotment Option</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8.5%">7.65</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8.5%">7.09</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8.5%">2.91</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8.5%">6.18</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8%">3.82</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8%">4.44</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8.5%">5.56</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8.5%">(0.19</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1%">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8.5%">10.19</td><td style="text-align: left; width: 1%"> </td></tr> </table> JATT Ventures II L.P We have until the date that is 24 months from the closing of this offering, or until such earlier liquidation date as our board of directors may approve, to consummate our initial business combination. If we anticipate that we may be unable to consummate our initial business combination within such 24-month period, we may seek shareholder approval to amend our articles to extend the date by which we must consummate our initial business combination. P24M true Nasdaq rules require that we must complete one or more business combinations having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account) at the time of the agreement to enter into the initial business combination. Our board of directors will make the determination as to the fair market value of our initial business combination. If our board of directors is not able to independently determine the fair market value of our initial business combination (including with the assistance of financial advisors), we will obtain an opinion from an independent investment banking firm which is a member of FINRA or another independent entity that commonly renders valuation opinions. While we consider it likely that our board of directors will be able to make an independent determination of the fair market value of our initial business combination, it may be unable to do so if it is less familiar or experienced with the business of a particular target or if there is a significant amount of uncertainty as to the value of the target’s assets or prospects. 0.80 Although our sponsor is permitted to undertake any activities permitted under the Limited Liabilities Partnership Act (As Revised) and other applicable law, our sponsor’s business is focused on investing in us and directly or indirectly providing office space and administrative services to members of our management team Dr. Someit Sidhu The following table sets forth the payments to be received by our sponsor and its affiliates from us prior to or in connection with the completion of our initial business combination and the securities issued and to be issued by us to our sponsor or its affiliates:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; width: 32%">Entity </td> <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center">Amount of Compensation to be Received or Securities Issued or to be Issued </td> <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 34%; text-align: center">Consideration Paid or to be Paid</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">JATT Ventures II L.P. </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">1,725,000 ordinary shares (of which 225,000 shares are subject to forfeiture if the underwriters do not exercise their over-allotment option). If we increase or decrease the size of this offering, we will effect a share capitalization or share repurchase or redemption or other appropriate mechanism, as applicable, with respect to our ordinary shares immediately prior to the consummation of the offering in such amount as to maintain the ownership of founder shares by our initial shareholders at 20% of our issued and outstanding ordinary shares upon the consummation of this offering (excluding the private placement shares). Prior to closing of this offering, our management team will receive indirect interest in founder shares through membership interests in our sponsor, including (i) to our Chief Executive Officer, Dr. Someit Sidhu 150,000 founder shares for his services, (ii) to our Chief Financial Officer, Mr. Nicholas Fernandez 50,000 founder shares for his services, (iii) to each of our independent directors 25,000 founder shares for their board services, and (iv) to an independent consultant 25,000 founder shares for his services in connection to this offering. Our management team may also purchase additional membership interests in our sponsor to receive indirect interest in ordinary shares held by our sponsor.</td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">$25,000 (approximately $0.014 per share)</td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; width: 32%">Entity </td> <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center">Amount of Compensation to be Received or Securities Issued or to be Issued </td> <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 34%; text-align: center">Consideration Paid or to be Paid</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">JATT Ventures II L.P. </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">300,000 private placement shares (or up to 309,000 private placement shares if the underwriters’ over-allotment option is exercised in full) </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">$3,000,000 ($10.00 per share) (or up to $3,090,000 if the underwriters’ over-allotment option is exercised in full)</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">JATT Ventures II L.P. and/or its affiliates or designees </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">$20,000 per month </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Officer compensation and administrative services provided to members of our management team (the “Administrative Service Fee”)</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">JATT Ventures II L.P. </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Repayment in cash </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Up to $300,000 under an unsecured, non-interest-bearing promissory note for offering-related and organizational expenses. The loan is due at the closing of this offering and are anticipated to be repaid upon completion of this offering.</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">JATT Ventures II L.P., our officers or directors, or affiliates thereof </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Repayment in cash </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">Dr. Someit Sidhu</td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Prior to closing of this offering, our Chief Executive Officer, Dr. Someit Sidhu will receive indirect interest in founder shares for his services through membership interests in our sponsor, representing 150,000 founder shares.</td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">$2,100 in aggregate (approximately $0.014 per share)</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">Mr. Nicholas Fernandez</td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Prior to closing of this offering, our Chief Financial Officer, Mr. Nicholas Fernandez will receive indirect interest in founder shares for his services through membership interests in our sponsor, representing 50,000 founder shares.</td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">$700 in aggregate (approximately $0.014 per share)</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">Independent directors </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Prior to closing of this offering, each of our independent directors will receive indirect interest in founder shares for their board services through membership interests in our sponsor, representing 25,000 founder shares.</td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">$1,400 in aggregate (approximately $0.014 per share)</td></tr> </table> 1725000 225000 150000 50000 25000 25000 25000 0.014 300000 3000000 10 20000 300000 150000 2100 0.014 50000 700 0.014 25000 1400 0.014 Pursuant to a letter agreement to be entered with us, we have agreed not to enter into a definitive agreement regarding an initial business combination without the prior consent of our sponsor. Further, pursuant to such letter agreement, our initial shareholders have agreed not to transfer, assign or sell any of their founder shares until the earlier to occur of: (i) 180 days after the completion of our initial business combination and (ii) the date on which we complete a liquidation, merger, share exchange or other similar transaction after our initial business combination that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property; and our sponsor has agreed not to transfer, assign or sell any of its private placement shares until 30 days after the completion of our initial business combination; except, in each case, to certain permitted transferees and under certain circumstances as described herein under “Principal Shareholders — Transfers of Founder Shares and Private Placement Shares”. Any permitted transferees will be subject to the same restrictions and other agreements of our initial shareholders with respect to any founder shares or private placement shares.<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="width: 23%; border-bottom: black 1pt solid">Subject Securities </td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 24%; border-bottom: black 1pt solid; text-align: center">Expiration Date </td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 18%; border-bottom: black 1pt solid; text-align: center">Persons Subject to Restrictions </td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 32%; border-bottom: black 1pt solid; text-align: center">Exceptions to Transfer Restrictions</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">Founder Shares </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">With certain limited exceptions, the founder shares are not transferable, assignable or saleable until the earlier of (A) 180 days after the completion of our initial business combination and (B) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">JATT Ventures II L.P. Dr. Someit Sidhu </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Transfers of the founder shares are permitted (a) to our officers or directors, any affiliate or family member of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate family, an affiliate of such individual or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of such individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or otherwise in connection with the consummation of our initial business combination at prices no greater than the price at which the securities were originally purchased; (f) in the event of our liquidation prior to the completion of an initial business combination; (g) by virtue of the laws of the Cayman Islands or our sponsor’s limited partnership agreement upon dissolution of our sponsor; or (h) in the event of our liquidation, merger, capital stock exchange or other similar transaction which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property subsequent to the completion of an initial business combination; provided, however, that in the case of clauses (a) through (e) or (g), these permitted transferees must enter into a written agreement with the company agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement (including provisions relating to voting, the trust account and liquidating distributions).</td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; width: 23%">Subject Securities </td> <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 24%; text-align: center">Expiration Date </td> <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: center">Persons Subject to Restrictions </td> <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center">Exceptions to Transfer Restrictions</td></tr> <tr style="vertical-align: top"> <td style="padding-left: 10pt; text-indent: -10pt">Private Placement Shares </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">The private placement shares are not transferable or saleable until 30 days after the completion of our initial business combination. </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">JATT Ventures II L.P. </td> <td style="white-space: nowrap"> </td> <td style="text-align: justify">Same as above.</td></tr> </table> With certain limited exceptions, the founder shares are not transferable, assignable or saleable until the earlier of (A) 180 days after the completion of our initial business combination and (B) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. JATT Ventures II L.P. Dr. Someit Sidhu Transfers of the founder shares are permitted (a) to our officers or directors, any affiliate or family member of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate family, an affiliate of such individual or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of such individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or otherwise in connection with the consummation of our initial business combination at prices no greater than the price at which the securities were originally purchased; (f) in the event of our liquidation prior to the completion of an initial business combination; (g) by virtue of the laws of the Cayman Islands or our sponsor’s limited partnership agreement upon dissolution of our sponsor; or (h) in the event of our liquidation, merger, capital stock exchange or other similar transaction which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property subsequent to the completion of an initial business combination; provided, however, that in the case of clauses (a) through (e) or (g), these permitted transferees must enter into a written agreement with the company agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement (including provisions relating to voting, the trust account and liquidating distributions). The private placement shares are not transferable or saleable until 30 days after the completion of our initial business combination. JATT Ventures II L.P. Same as above. Redemption rights for public shareholders in connection with completion of our initial business combination:We will provide our public shareholders with the opportunity to redeem all or a portion of their public shares in connection with the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation of our initial business combination, including interest earned on the funds held in the trust account (less taxes paid or payable (other than excise or similar taxes)), divided by the number of then issued and outstanding public shares, subject to the limitations and on the conditions described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriter. There will be no redemption rights in connection with the completion of our initial business combination with respect to our private placement shares. Our sponsor, officers, directors and advisors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, private placement shares and any public shares they may acquire during or after this offering in connection with the completion of our initial business combination. Adjusted NTBVPS excludes the effect of the consummation of our initial business combination or any related transactions or expenses. The calculation of Adjusted NTBVPS assumes that no ordinary shares are issued to shareholders of our potential initial business combination target as consideration or issuable by the post-business combination company (for example, under an incentive plan or employee share purchase plan), no ordinary shares or convertible equity, equity-linked or debt securities are issued in connection with additional financing that we may seek in connection with our initial business combination, and no working capital loans are converted into private placement shares. The issuance of additional ordinary or preference shares may significantly dilute the equity interest of investors in this offering and are likely to increase as the enterprise value of a prospective target company increases. We intend to target businesses with enterprise values that are greater than we could acquire with the net proceeds of this offering and the sale of the private placement shares. At February 13, 2026, our net tangible book deficit was $28,206, or approximately $(0.02) per ordinary share. The following table illustrates what the Adjusted NTBVPS at February 13, 2026, would have been to the public shareholders on a pro forma basis to give effect to this offering and the issuance of the private placement shares, assuming no exercise of the over-allotment option and exercise of the over-allotment option in full:<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">No Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">25% of Maximum Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">50% of Maximum Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">75% of Maximum Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maximum Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 25%">Public offering price</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left">$</td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">10.00</td><td style="width: 0.5%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net tangible book deficit before this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Increase (decrease) attributable to public shareholders</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.67</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.68</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.11</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.12</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6.20</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6.21</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4.46</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4.46</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.17</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.26</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Pro forma net tangible book value (decrease) after this offering and the sale of the private placement shares</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.65</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.66</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.09</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.10</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6.18</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6.19</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4.44</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4.44</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.19</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.28</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Dilution to public shareholders</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2.35</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">2.34</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">2.91</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">2.90</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3.82</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3.81</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5.56</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5.56</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10.19</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10.28</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Percentage of dilution to public shareholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23.50</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23.40</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29.10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29.00</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38.20</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38.10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55.60</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55.60</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">101.90</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">102.80</td><td style="text-align: left">%</td></tr> </table>For each of the redemption scenarios above, the NTBV was calculated as follows:<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">25% of Maximum Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">50% of Maximum Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">75% of Maximum Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maximum Redemptions</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Full Over- Allotment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Numerator:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 25%; text-align: left; text-indent: -10pt; padding-left: 10pt">Net tangible book deficit before this offering</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left">$</td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td><td style="width: 0.5%"> </td> <td style="width: 0.5%; text-align: left"> </td><td style="width: 6%; text-align: right">(28,206</td><td style="width: 0.5%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Plus: Net proceeds from this offering and sale of the private placement shares(1)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70,500,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Plus: Offering costs paid in advance, excluded from tangible book value before this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,619</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Less: Deferred underwriting fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,800,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,070,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,800,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,070,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,800,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,070,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,800,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,070,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,800,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,070,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Less: Over-allotment liability(2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Less: Amounts paid for redemptions(3)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,250,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(30,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,500,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(45,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(51,750,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(60,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(69,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">59,649,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">68,435,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">44,649,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">51,185,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">29,649,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">33,935,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">14,649,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">16,685,413</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">(350,587</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">(564,587</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-indent: -10pt; padding-left: 10pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">ordinary shares outstanding prior to this offering(4)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Less: ordinary shares forfeited if over-allotment is not exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(225,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(225,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(225,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(225,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(225,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Plus: ordinary shares offered</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -10pt; padding-left: 10pt">Private placement shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">309,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">309,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">309,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">309,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">309,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Less: ordinary shares redeemed</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,500,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,725,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,450,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,500,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,175,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,900,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">7,800,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">8,934,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">6,300,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">7,209,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">4,800,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5,484,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3,300,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3,759,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,800,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">2,034,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Expenses applied against gross proceeds include offering expenses of approximately $900,000 (not including $625,000 for director and officer liability insurance premiums to be paid upon closing of this offering, which amount is not an offering expense to be capitalized) and underwriting commissions of $600,000. See “Use of Proceeds.”</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Represents the value of 45-day over-allotment option from the date of this offering granted to the underwriters to purchase an aggregate of up to 900,000 additional ordinary shares at the initial public offering price less the underwriting commissions. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the shares subject to redemption and will be accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the initial public offering. The table above assumes that the option has either been fully exercised or has expired with no exercise to purchase additional shares, thus the value of over-allotment liability in both scenario is $56,000.</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, initial shareholders, directors, executive officers, advisors or their affiliates may purchase shares in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of ordinary shares subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma NTBV. See “Proposed Business — Effecting Our Initial Business Combination — Permitted Purchases of Our Securities.”</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">For purposes of presenting the maximum redemption scenario, we have reduced our pro forma net tangible book value after this offering (assuming no exercise of the underwriters’ option to purchase additional shares) by $60,000,000 because holders of up to approximately 100% of our public shares may redeem their shares for a pro rata share of the aggregate amount then on deposit in the trust account at a per share redemption price equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account less taxes paid or payable (other than excise or similar taxes), divided by the number of then issued and outstanding public shares, subject to the limitations and on the conditions described herein.</td> </tr></table> 10 10 10 10 10 10 10 10 10 10 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 7.67 7.68 7.11 7.12 6.2 6.21 4.46 4.46 -0.17 -0.26 7.65 7.66 7.09 7.1 6.18 6.19 4.44 4.44 -0.19 -0.28 2.35 2.34 2.91 2.9 3.82 3.81 5.56 5.56 10.19 10.28 -28206 -28206 -28206 -28206 -28206 -28206 -28206 -28206 -28206 -28206 61500000 70500000 61500000 70500000 61500000 70500000 61500000 70500000 61500000 70500000 33619 33619 33619 33619 33619 33619 33619 33619 33619 33619 -1800000 -2070000 -1800000 -2070000 -1800000 -2070000 -1800000 -2070000 -1800000 -2070000 -56000 -56000 -56000 -56000 -56000 -15000000 -17250000 -30000000 -34500000 -45000000 -51750000 -60000000 -69000000 59649413 68435413 44649413 51185413 29649413 33935413 14649413 16685413 -350587 -564587 1725000 1725000 1725000 1725000 1725000 1725000 1725000 1725000 1725000 1725000 -225000 -225000 -225000 -225000 -225000 6000000 6900000 6000000 6900000 6000000 6900000 6000000 6900000 6000000 6900000 300000 309000 300000 309000 300000 309000 300000 309000 300000 309000 -1500000 -1725000 -3000000 -3450000 -4500000 -5175000 -6000000 -6900000 7800000 8934000 6300000 7209000 4800000 5484000 3300000 3759000 1800000 2034000 Directors’ Fiduciary Duties and Conflicts of InterestAs a matter of Cayman Islands law, a director of a Cayman Islands company is in the position of a fiduciary with respect to the company. Accordingly, directors and officers owe the following fiduciary duties:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify">duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: justify">directors should not improperly fetter the exercise of future discretion;</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(iv)</td><td style="text-align: justify">duty to exercise authority for the purpose for which it is conferred and a duty to exercise powers fairly as between different sections of shareholders;</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(v)</td><td style="text-align: justify">duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(vi)</td><td style="text-align: justify">duty to exercise independent judgment.</td> </tr></table>In addition to the above, directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge, skill and experience of that director.As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the memorandum and articles of association or alternatively by shareholder approval at general meetings.Each of our executive officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations to at least one other entity pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our executive officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, subject to their fiduciary duties under Cayman Islands law. Our articles will provide that we, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an executive officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which may (a) be a corporate opportunity for any director or officer, on the one hand, and us, on the other, or (b) the presentation of which would breach an existing legal obligation of a member of director, officer or sponsor to any other entity. The purpose for the surrender of corporate opportunities is to allow officers, directors or other representatives with multiple business affiliations to continue to serve as an officer of our company or on our board of directors. Our officers and directors may from time to time be presented with opportunities that could benefit both another business affiliation and us. In the absence of the “corporate opportunity” waiver in our articles, certain candidates would not be able to serve as an officer or director. We believe we substantially benefit from having representatives who bring significant, relevant and valuable experience to our management, and, as a result, the inclusion of the “corporate opportunity” waiver in our articles provide us with greater flexibility to attract and retain the officers and directors that we feel are the best candidates. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our initial business combination.Below is a table summarizing the entities to which our executive officers and directors currently have fiduciary duties or contractual obligations:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; width: 25%; font-weight: bold">Individual</td><td style="vertical-align: bottom; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; vertical-align: bottom; width: 24%; font-weight: bold; text-align: center">Entity</td><td style="vertical-align: bottom; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; vertical-align: bottom; width: 24%; font-weight: bold; text-align: center; padding-bottom: 1.5pt">Entity’s Business</td><td style="vertical-align: bottom; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; vertical-align: bottom; width: 24%; font-weight: bold; text-align: center">Affiliation</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Dr. Someit Sidhu</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Zura Bio Limited</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Khanda Therapeutics</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="vertical-align: top; text-align: left">Founder, Chief Executive Officer, and Director</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">GSN Estate</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Property Management</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Invictus Bioscience</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Nicholas Fernandez</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Liminatus Pharma, LLC</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Iris Acquisition Corp</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">SPAC</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Amanat Acquisition Corp</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">SPAC</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Chief Financial Officer</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Verender S. Badial</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Cryfield Investments Ltd</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Investment Management</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Managing Director</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">ME Asset Management Ltd</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Asset Management</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Chief Executive Officer</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Christopher Staral</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Triple Helix Investments, LLC.</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Investment Management</td><td style="text-align: left; vertical-align: top"> </td> <td style="vertical-align: top; text-align: left">Founder, Managing Member, and Chief Investment Officer</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Dr. Arjun Goyal</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Centessa Pharmaceuticals Plc</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> </table>In addition, our sponsor and members of our sponsor, officers and directors, and their affiliates and/or related parties may sponsor, form or participate in the formation of, or become an officer or director of, invest or otherwise become affiliated with, other blank check companies, including in connection with their initial business combinations, or may pursue other business or investment ventures, even prior to us entering into a definitive agreement for our initial business combination or completing our initial business combination. Any such companies, businesses or investments would present additional conflicts of interest in pursuing an initial business combination. Potential investors should also be aware of the following other potential conflicts of interest:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify">Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our executive officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our officers are not obligated to contribute any specific number of hours per week to our affairs.</td></tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify">Our initial shareholders purchased founder shares prior to the date of this prospectus and our sponsor will purchase private placement shares in a transaction that will close simultaneously with the closing of this offering. Our sponsor, officers, directors and advisors will entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection with the completion of our initial business combination. Additionally, our sponsor, officers, directors and advisors will agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares and private placement shares if we fail to complete our initial business combination within the prescribed time frame, although they will be entitled to liquidating distributions from assets outside the trust account. Furthermore, our sponsor, officers, directors and advisors have agreed not to transfer, assign or sell any of their founder shares until the earlier to occur of: (i) 180 days after the completion of our initial business combination or (ii) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property and our sponsor has agreed not to transfer, assign or sell any of its private placement shares until 30 days after the completion of our initial business combination. Because each of our officers and director nominees will own ordinary shares directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination and in negotiating or accepting the terms of the transaction because of their financial interest in completing an initial business combination within the completion window.</td></tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify">Our officers, directors and advisors will directly or indirectly own founder shares and/or private placement shares following this offering and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination and in negotiating or accepting the terms of the transaction because of their financial interest in completing an initial business combination within the completion window. The low price that our sponsor, officers, directors and advisors (directly or indirectly) paid for the founder shares creates an incentive whereby our officers and directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. If we are unable to complete our initial business combination within the completion window, the founder shares may expire worthless, except to the extent they receive liquidating distributions from assets outside the trust account, which could create an incentive for our sponsor, executive officers and directors to complete a transaction even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. Further, each of our officers, directors and advisors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers, directors and advisors was included by a target business as a condition to any agreement with respect to our initial business combination.</td></tr></table>We are not prohibited from pursuing an initial business combination with a business combination target that is affiliated with our sponsor, officers or directors or completing the business combination through a joint venture or other form of shared ownership with our sponsor, officers or directors. In the event we seek to complete our initial business combination with a business combination target that is affiliated with our sponsor, officers or directors, we, or a committee of independent directors, would obtain an opinion from an independent investment banking which is a member of FINRA or another independent entity that commonly renders valuation opinions, that such initial business combination is fair to our company from a financial point of view. We are not required to obtain such an opinion in any other context. Furthermore, in no event will our sponsor or any of our existing officers or directors, or any of their respective affiliates, be paid by the company any finder’s fee, consulting fee or other compensation prior to, or for any services they render in order to effectuate, the completion of our initial business combination (regardless of the type of transaction that it is). However, commencing on the date the securities of the Company are first listed on Nasdaq, we will also pay our sponsor $20,000 per month for officer compensation and administrative services provided to members of our management team.We cannot assure you that any of the above mentioned conflicts will be resolved in our favor.In the event that we submit our initial business combination to our public shareholders for a vote, our sponsor, officers, directors and advisors have agreed to vote their founder shares, and they and the other members of our management team have agreed to vote their founder shares and any shares purchased during or after the offering in favor of our initial business combination. Below is a table summarizing the entities to which our executive officers and directors currently have fiduciary duties or contractual obligations:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; width: 25%; font-weight: bold">Individual</td><td style="vertical-align: bottom; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; vertical-align: bottom; width: 24%; font-weight: bold; text-align: center">Entity</td><td style="vertical-align: bottom; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; vertical-align: bottom; width: 24%; font-weight: bold; text-align: center; padding-bottom: 1.5pt">Entity’s Business</td><td style="vertical-align: bottom; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; vertical-align: bottom; width: 24%; font-weight: bold; text-align: center">Affiliation</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Dr. Someit Sidhu</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Zura Bio Limited</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Khanda Therapeutics</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="vertical-align: top; text-align: left">Founder, Chief Executive Officer, and Director</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">GSN Estate</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Property Management</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Invictus Bioscience</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Nicholas Fernandez</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Liminatus Pharma, LLC</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Iris Acquisition Corp</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">SPAC</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Amanat Acquisition Corp</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">SPAC</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Chief Financial Officer</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Verender S. Badial</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Cryfield Investments Ltd</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Investment Management</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Managing Director</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"> </td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">ME Asset Management Ltd</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Asset Management</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Chief Executive Officer</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Christopher Staral</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Triple Helix Investments, LLC.</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Investment Management</td><td style="text-align: left; vertical-align: top"> </td> <td style="vertical-align: top; text-align: left">Founder, Managing Member, and Chief Investment Officer</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Dr. Arjun Goyal</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Centessa Pharmaceuticals Plc</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Biotechnology</td><td style="text-align: left; vertical-align: top"> </td> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Director</td></tr> </table> Our executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our executive officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our officers are not obligated to contribute any specific number of hours per week to our affairs. Our initial shareholders purchased founder shares prior to the date of this prospectus and our sponsor will purchase private placement shares in a transaction that will close simultaneously with the closing of this offering. Our sponsor, officers, directors and advisors will entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, private placement shares and public shares in connection with the completion of our initial business combination. Additionally, our sponsor, officers, directors and advisors will agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares and private placement shares if we fail to complete our initial business combination within the prescribed time frame, although they will be entitled to liquidating distributions from assets outside the trust account. Furthermore, our sponsor, officers, directors and advisors have agreed not to transfer, assign or sell any of their founder shares until the earlier to occur of: (i) 180 days after the completion of our initial business combination or (ii) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property and our sponsor has agreed not to transfer, assign or sell any of its private placement shares until 30 days after the completion of our initial business combination. Because each of our officers and director nominees will own ordinary shares directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination and in negotiating or accepting the terms of the transaction because of their financial interest in completing an initial business combination within the completion window. Our officers, directors and advisors will directly or indirectly own founder shares and/or private placement shares following this offering and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination and in negotiating or accepting the terms of the transaction because of their financial interest in completing an initial business combination within the completion window. The low price that our sponsor, officers, directors and advisors (directly or indirectly) paid for the founder shares creates an incentive whereby our officers and directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. If we are unable to complete our initial business combination within the completion window, the founder shares may expire worthless, except to the extent they receive liquidating distributions from assets outside the trust account, which could create an incentive for our sponsor, executive officers and directors to complete a transaction even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. Further, each of our officers, directors and advisors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers, directors and advisors was included by a target business as a condition to any agreement with respect to our initial business combination. S-1/A Corporation 0002112446 true